Evaluate the Efficacy and Safety of DWJ211 in Patient With Moderate or Severe Submental Fat

NCT03946592 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

148

Enrollment

INDUSTRY

Sponsor class

Conditions

Submental Fat

Interventions

DRUG: Normal saline
DRUG: DWJ211

Sponsor

Daewoong Pharmaceutical Co. LTD.